Novartis Provides Update on AVXS-101 Intrathecal Clinical Development Program

NEXT STORY
GW Pharmaceuticals receives Australian Therapeutic Goods Administration (TGA) approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy
PREV STORY
Global Surgical Fluid Disposal Products Industry
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CHMP recommends EU approval of Roche’s Kadcyla for the adjuvant treatment of people with HER2-positive early breast cancer with residual invasive disease after neoadjuvant treatment

author_avatar
NASDAQ Market News

RedHill Biopharma Announces Positive Top-Line Results from Phase III Study of RHB-104 in Crohn’s Disease

Primary endpoint successfully achieved - superior remission rate at week 26 in patients treated ...

author_avatar
NASDAQ Market News

ABOG Appoints New Chair and Members of Subspecialty Divisions

author_avatar
NASDAQ Market News